Hillstream Biopharma Inc (HILS) Stock
HILS is no longer traded. Hillstream Biopharma was delisted from the Nasdaq in November 2023.
Prices on this page are historical; the last trade was November 24, 2023 at $2.88.
Hillstream Biopharma stock price history
HILS final trading statistics
- Final close
- $2.88
- Final trading day
- Nov 24, 2023
- Market cap at delisting
- $4.17M
- Shares outstanding
- 17.60M
- Final 52-week range
- $0.14 – $5.31
- Avg. volume (final 3 mo.)
- 157,261
- All-time high (split-adj.)
- $1968.75 · Nov 2023
- All-time low (split-adj.)
- $43.12 · Nov 2023
- Return since IPO
- -96.7%
- Beta
- —
- Book value / share
- $0.18
- Price / book
- 15.71
Hillstream Biopharma annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2022 | $0.00 | -$8.5M | -$0.26 |
| FY2021 | $0.00 | -$3.0M | -$0.69 |
| FY2020 | $0.00 | -$2.4M | -$0.46 |
| FY2019 | $0.00 | -$1.2M | -$0.07 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Hillstream Biopharma Inc
Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) and targeted immuno-oncology novel biologics for the treatment drug resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-3215, an anti-HER2 monoclonal antibody candidate; and HSB-1940, a Quatrabody that is a proprietary IO biologic in development targeting PD-1. The company was incorporated in 2017 and is based in Bridgewater, New Jersey.
Hillstream Biopharma stock FAQ
What happened to Hillstream Biopharma stock?
Hillstream Biopharma stock was delisted from the Nasdaq. Its final close was $2.88 on November 24, 2023.
Is HILS stock still trading?
No. HILS was delisted from the Nasdaq in November 2023 and no longer trades on a U.S. exchange.
What was the last price of HILS stock?
HILS closed at $2.88 on its final trading day, November 24, 2023, for a market value of about $4.17M.
What were Hillstream Biopharma's revenue and earnings in its last full fiscal year?
Hillstream Biopharma reported revenue of $0.00 and net income of -$8.5M in fiscal 2022, its last full year as a public company.
When did Hillstream Biopharma go public?
Hillstream Biopharma Inc stock began trading on January 12, 2022.